ERBB2 and cancer: Previously, the heterogenic features of cancer were calibrated, based on the following parameters: histological analysis, tumor grading, condition of lymph nodes, and specific markers, such as estrogen receptor (ER), progesterone receptor (PR), and, recently, human epidermal growth factor receptor 2 (HER2) [43].